ImClone Posts Profit on Erbitux Sales ImClone Systems Inc. (IMCL.O: Quote, Profile, Research) on Thursday posted its third successive quarterly profit helped by strong sales of its new colon cancer drug Erbitux. 
Is this a piece of news regarding world politics, sports, business, or science and technology? 